Livtencity Disease Interactions
There are 2 disease interactions with Livtencity (maribavir).
Maribavir (applies to Livtencity) liver impairment
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
No dose adjustment of maribavir is required in patients with mild (Child-Pugh A) or moderate (Child-Pugh B) liver dysfunction. Maribavir has not been studied in patients with severe liver dysfunction; caution is recommended.
Maribavir (applies to Livtencity) renal impairment
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Renal Dysfunction
No dose adjustment of maribavir is required in patients with mild, moderate, or severe renal dysfunction. Maribavir has not been studied in patients with end-stage renal disease, including those on dialysis; caution is recommended.
Switch to professional interaction data
Livtencity drug interactions
There are 291 drug interactions with Livtencity (maribavir).
Report options
More about Livtencity (maribavir)
- Livtencity consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antivirals
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
